Abstract
Dyslipidaemia poses a significant challenge in the paediatric population, mostly due to the fact that serum lipid abnormalities in children are often missed. It has been shown that the lack of routine screening in children and adolescents may account for as many as half of this population, with either inherited or acquired cholesterol abnormalities, being missed during childhood. This article provides a high-level overview of dyslipidaemia in children and adolescents, including the screening and management of lipid abnormalities in the paediatric population.
| Original language | English |
|---|---|
| Pages (from-to) | 38-42 |
| Number of pages | 5 |
| Journal | SA Pharmaceutical Journal |
| Volume | 83 |
| Issue number | 7 |
| Publication status | Published - 2016 |
Keywords
- Atherosclerosis
- Dyslipidaemia
- Familial hypercholesterolaemia
- Lipid screening
- Statins